Fluarix Tetra 2022/2023 NH

Introduction of Fluarix Tetra 2022/2023 NH 0.5 ml

Fluarix Tetra 2022/2023 NH helps protect you from influenza (flu). Fluarix Tetra 2021/2022 NH Vaccine is made from inactivated (dead) influenza virus. Fluarix Tetra 2022/2023 NH is given as an injection and is typically administered to adults and children over 6 months of age. The Fluarix Tetra 2021/2022 NH Injection is designed to protect against the three most common strains of influenza (influenza A and B) that are expected to circulate in a given year. Fluarix Tetra 2021/2022 NH Vaccine works by stimulating the immune system to produce antibodies against the influenza virus, which can then provide protection against the virus if a person is exposed to it. The Fluarix Tetra 2021/2022 NH Injection is considered to be safe and is typically administered annually to help protect against seasonal influenza.

Getting the Fluarix Tetra 2021/2022 NH may cause mild side effects, however,Fluarix Tetra 2021/2022 NH Vaccine is safer to be vaccinated than to contract influenza. The flu can result in thousands of deaths annually. Common side effects of the Fluarix Tetra Vaccine include headaches, fatigue, weakness, and pain/swelling at the injection site. These symptoms typically do not last long. If you have any concerns about the side effects, it is best to consult with your doctor.

It is important to inform your doctor of any current illnesses or fever, and any past allergic reactions to vaccines before receiving the Fluarix Tetra 2021/2022 NH Vaccine. Additionally, it is essential to discuss any current medications you may be taking as they may interact with the Fluarix Tetra 2022/2023 NH. Though it may not provide full protection, the Fluarix Tetra 2021/2022 NH Injection can still reduce symptoms if you do contract the flu. However, it will not protect against avian flu or the common cold. If you are pregnant or breastfeeding, it is recommended to consult with your doctor before getting the Fluarix Tetra Vaccine.

Uses of Fluarix Tetra 2022/2023 NH 0.5 ml

Prevention of Influenza (flu): Fluarix Tetra 2022/2023 NH is used to prevent Influenza, also known as the flu, is a contagious respiratory illness caused by influenza viruses. Symptoms include fever, cough, sore throat, runny or stuffy nose, muscle or body aches, fatigue, and sometimes vomiting and diarrhoea. The flu can range in severity from mild to severe, and can lead to complications such as pneumonia, bronchitis, and sinus and ear infections.

Benefits of Fluarix Tetra 2022/2023 NH 0.5 ml

Fluarix Tetra 2021/2022 NH Vaccine helps protect against the most common strains of the flu virus, reducing the risk of contracting the flu.

The Fluarix Tetra 2022/2023 NH is particularly important for vulnerable populations, such as young children, the elderly, and people with certain medical conditions, as they are at a higher risk of complications from the flu.

Fluarix Tetra Vaccine can help prevent hospitalizations and deaths related to the flu.

When more people are vaccinated, the spread of the flu in a community is reduced, which helps protect people who are unable to get vaccinated, such as infants and people with certain medical conditions.

Fluarix Tetra Vaccine is an inexpensive way to prevent flu and its complications, it is also considered cost-effective as it saves on the cost of treating flu-related complications, absenteeism, and lost productivity.

Side Effects of Fluarix Tetra 2022/2023 NH 0.5 ml

​​​​Like all medications, Fluarix Tetra 2022/2023 NH can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.​

Most Common Side Effects of Fluarix Tetra 2022/2023 NH 0.5 ml

• Headache
  
• Muscle aches

Common Side Effects of Fluarix Tetra 2022/2023 NH 0.5 ml

• Soreness, redness, or swelling at the injection site
• Low-grade fever
• Fatigue

How to Use Fluarix Tetra 2022/2023 NH 0.5 ml?

​​​​​​​​Fluarix Tetra 2021/2022 NH Vaccine is administered by a healthcare professional or nurse in a hospital or clinic setting. The specific dosing and administration of Fluarix Tetra 2021/2022 NH Injection will depend on the clinical condition of the patient's age and medical history, and other factors. Kindly do not self-administer.​​

How Fluarix Tetra 2022/2023 NH 0.5 ml Works?

Fluarix Tetra 2022/2023 NH also known as "killed" influenza vaccines, are made from inactivated (killed) forms of the influenza virus. Fluarix Tetra Vaccine injected into the body and stimulate an immune response, which includes the production of antibodies that protect against the specific strains of influenza included in the vaccine. The Fluarix Tetra 2021/2022 NH Vaccine does not cause the flu, as the virus is dead and cannot infect the person receiving the vaccine. Fluarix Tetra 2021/2022 NH Vaccine typically takes about two weeks for the body to develop immunity after receiving the Fluarix Tetra 2021/2022 NH Injection.

Safety Advices Fluarix Tetra 2022/2023 NH 0.5 ml

Alcohol

Unsafe

Driving

Safe

Kidney

Use with Caution

Liver

Use with Caution

Breastfeeding

Safe

Pregnancy

Safe

References

1. INFLUVAC Tetra, suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated), Abbott Laboratories Ltd., Product Leaflet

2. FLUARIX QUADRIVALENT (Influenza Vaccine) injectable suspension, for intramuscular use, [Revised: 07/2022], GlaxoSmithKline Biologicals, Dresden, Germany, Product Leaflet 

3. Influvac Tetra, suspension for injection in a pre-filled syringe Influenza vaccine (surface antigen, inactivated) 2022/2023 season, Abbott Biologicals B.V. Product Leaflet 

4. INFLUVAC TETRA Quadrivalent influenza vaccine, surface antigen, inactivated Suspension for Injection, each 0.5 mL pre-filled syringe contains neuraminidase and 15 mcg haemagglutinin of each virus strain as recommended by the WHO and NACI, intramuscular injection or deep subcutaneous injection, BGP Products B.V., licensed use by BGP Pharma ULC, Etobicoke, Ontario, [Date of Revision:MAY 13, 2022], Product Monograph​